Article

Drug repurposing through nonhypothesis driven phenotypic screening

2011-10-28

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c9edae7e-dd69-53c3-9b92-8439950d0d29
DOI: 10.1016/j.ddstr.2011.09.007

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Drug repurposing through nonhypothesis driven phenotypic screeningDOI 10.1016/j.ddstr.2011.09.007Read

Bridging the gap between target-based and phenotypic-based drug discovery.Semantic proximity Read

The future of phenotypic drug discovery.Semantic proximity Read

Pharmacogenetics and drug development: the path to safer and more effective drugsSemantic proximity Read

DRUG REPURPOSING-Overcoming the translational hurdles to clinical use.Semantic proximity Read

How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of Practice.Semantic proximity Read

Target Mutation-Driven Drug Discovery.Semantic proximity Read

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug Discovery.Semantic proximity Read

Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches.Semantic proximity Read

Phenotypic screening: A more rapid route to target deconvolution.Semantic proximity Read

Phenotypic screens as a renewed approach for drug discovery.Semantic proximity Read

The Resurrection of Phenotypic Drug DiscoverySemantic proximity Read

Transitioning pharmacoperones to therapeutic use: In vivo proof-of-principle and design of high throughput screensSemantic proximity Read